A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Rifampicin Capsules (RIF)
Clinical trial NCT07002255 · COMPLETED
Trial details
- NCT number
- NCT07002255
- Sponsor
- Henan Genuine Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2022-03-22
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.